-
2
-
-
0034620302
-
Improving the quality of the cannabis debate: Defining the different domains
-
Strang J, Witton J, Hall W. Improving the quality of the cannabis debate: defining the different domains. BMJ. 2000;320:108-110.
-
(2000)
BMJ
, vol.320
, pp. 108-110
-
-
Strang, J.1
Witton, J.2
Hall, W.3
-
3
-
-
0442307621
-
Causal association between cannabis and psychosis: Examination of the evidence
-
Arseneault L, Cannon M, Witton J, et al. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry. 2004;184:111-117.
-
(2004)
Br J Psychiatry
, vol.184
, pp. 111-117
-
-
Arseneault, L.1
Cannon, M.2
Witton, J.3
-
4
-
-
0035136656
-
Psychiatric effects of cannabis
-
Johns A. Psychiatric effects of cannabis. Br J Psychiatry. 2001;178:116-122.
-
(2001)
Br J Psychiatry
, vol.178
, pp. 116-122
-
-
Johns, A.1
-
5
-
-
0028316414
-
Cannabis abuse and the course of recent onset schizophrenic disorders
-
Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent onset schizophrenic disorders. Arch Gen Psychiatry. 1994;51:273-279.
-
(1994)
Arch Gen Psychiatry
, vol.51
, pp. 273-279
-
-
Linszen, D.H.1
Dingemans, P.M.2
Lenior, M.E.3
-
6
-
-
0032517566
-
Adverse effects of cannabis
-
Hall W, Solowij N. Adverse effects of cannabis. Lancet. 1998;352:1611-1616.
-
(1998)
Lancet
, vol.352
, pp. 1611-1616
-
-
Hall, W.1
Solowij, N.2
-
8
-
-
35549010993
-
Cannabis, the mind and society: The hash realities
-
Murray RM, Morrison PD, Henquet C, et al. Cannabis, the mind and society: the hash realities. Nat Rev Neurosci. 2007;8:885-895.
-
(2007)
Nat Rev Neurosci
, vol.8
, pp. 885-895
-
-
Murray, R.M.1
Morrison, P.D.2
Henquet, C.3
-
9
-
-
34447619511
-
Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review
-
Moore THM, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370:319-328.
-
(2007)
Lancet
, vol.370
, pp. 319-328
-
-
Moore, T.H.M.1
Zammit, S.2
Lingford-Hughes, A.3
-
10
-
-
0035424139
-
Treatment of the schizophrenia prodrome: Is it presently ethical?
-
Cornblatt B, Lencz T, Kane J. Treatment of the schizophrenia prodrome: is it presently ethical? Schizophr Res. 2001;52:31-38.
-
(2001)
Schizophr Res
, vol.52
, pp. 31-38
-
-
Cornblatt, B.1
Lencz, T.2
Kane, J.3
-
11
-
-
0036498851
-
The schizophrenia prodrome: Treatment and high-risk perspectives
-
Cornblatt B, Lencz T, Obuchowski M. The schizophrenia prodrome: treatment and high-risk perspectives. Schizophr Res. 2002;54:177-186.
-
(2002)
Schizophr Res
, vol.54
, pp. 177-186
-
-
Cornblatt, B.1
Lencz, T.2
Obuchowski, M.3
-
12
-
-
0029097166
-
The prevalence of prodromal features of schizophrenia in adolescence: A preliminary survey
-
McGorry PD, MacFarlane C, Patton GC, et al. The prevalence of prodromal features of schizophrenia in adolescence: a preliminary survey. Acta Psychiatr Scand. 1995;92:241-249.
-
(1995)
Acta Psychiatr Scand
, vol.92
, pp. 241-249
-
-
McGorry, P.D.1
MacFarlane, C.2
Patton, G.C.3
-
13
-
-
0029882958
-
The prodromal phase of first-episode psychosis: Past and current conceptualizations
-
Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophrenia Bull. 1996;22:353-370.
-
(1996)
Schizophrenia Bull
, vol.22
, pp. 353-370
-
-
Yung, A.R.1
McGorry, P.D.2
-
14
-
-
0037333669
-
Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group
-
Yung AR, Philips LJ, Yuen HP, et al. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res. 2003;60:21-32.
-
(2003)
Schizophr Res
, vol.60
, pp. 21-32
-
-
Yung, A.R.1
Philips, L.J.2
Yuen, H.P.3
-
15
-
-
0037164359
-
Cannabis use and mental health in young people: Cohort study
-
Patton GC, Coffey C, Carlin JB, et al. Cannabis use and mental health in young people: cohort study. BMJ. 2002;325:1195-1198.
-
(2002)
BMJ
, vol.325
, pp. 1195-1198
-
-
Patton, G.C.1
Coffey, C.2
Carlin, J.B.3
-
16
-
-
0037255987
-
Pharmacokinetics and pharmacodynamics of cannabinoids
-
Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;24:327-360.
-
(2003)
Clin Pharmacokinet
, vol.24
, pp. 327-360
-
-
Grotenhermen, F.1
-
17
-
-
0026769858
-
The structured clinical interview for DSM-III-R (SCID). I: History, rationale, and description
-
Spitzer RL, Williams JB, Gibbon M, et al. The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry. 1992;49(8):642-1629
-
(1992)
Arch Gen Psychiatry
, Issue.498
, pp. 642-1629
-
-
Spitzer, R.L.1
Williams, J.B.2
Gibbon, M.3
-
18
-
-
0036241144
-
Prospective diagnosis of the initial prodrome for schizophrenia based on the structured interview for prodromal syndromes: Preliminary evidence of interpreter reliability and predictive validity
-
Miller TJ, McGlashan TH, Lifshey Rosen J, et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the structured interview for prodromal syndromes: preliminary evidence of interpreter reliability and predictive validity. Am J Psychiatry. 2002;159:863-865.
-
(2002)
Am J Psychiatry
, vol.159
, pp. 863-865
-
-
Miller, T.J.1
McGlashan, T.H.2
Lifshey Rosen, J.3
-
20
-
-
0031914835
-
The psychometric properties of the composite international diagnostic interview
-
Andrews G, Peters L. The psychometric properties of the composite international diagnostic interview. Soc Psychiatry Psychr Epidemiol. 1998;33:80-88.
-
(1998)
Soc Psychiatry Psychr Epidemiol
, vol.33
, pp. 80-88
-
-
Andrews, G.1
Peters, L.2
-
21
-
-
0026534304
-
IRAOS: An instrument for the assessment of onset and early course of schizophrenia
-
Häfner H, Riecher-Rössler A, Hambrecht M, et al. IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr Res. 1992;6:209-223.
-
(1992)
Schizophr Res
, vol.6
, pp. 209-223
-
-
Häfner, H.1
Riecher-Rössler, A.2
Hambrecht, M.3
-
22
-
-
0037639116
-
Sex differences in the risk of schizophrenia: Evidence from meta-analysis
-
Aleman A, Kahn RS, Selten JP. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry. 2003;60:565-571.
-
(2003)
Arch Gen Psychiatry
, vol.60
, pp. 565-571
-
-
Aleman, A.1
Kahn, R.S.2
Selten, J.P.3
-
23
-
-
0027441604
-
The influence of age and sex on the onset and early course of Schizophrenia
-
Häfner H, Maurer K, Löffler W, et al. The influence of age and sex on the onset and early course of Schizophrenia. Br J Psychiatry. 1993;162:80-86.
-
(1993)
Br J Psychiatry
, vol.162
, pp. 80-86
-
-
Häfner, H.1
Maurer, K.2
Löffler, W.3
-
24
-
-
4944222090
-
Cannabis use and psychotic disorders: An update
-
Hall W, Degenhardt L, Teesson M. Cannabis use and psychotic disorders: an update. Drug Alcohol Rev. 2004;23:433-443.
-
(2004)
Drug Alcohol Rev
, vol.23
, pp. 433-443
-
-
Hall, W.1
Degenhardt, L.2
Teesson, M.3
-
25
-
-
18444369604
-
Cannabis use predicts future psychotic symptoms, and vice versa
-
Ferdinand RF, Sondeijker F, van der Ende J, et al. Cannabis use predicts future psychotic symptoms, and vice versa. Addiction. 2005;100:612-618.
-
(2005)
Addiction
, vol.100
, pp. 612-618
-
-
Ferdinand, R.F.1
Sondeijker, F.2
Van Der Ende, J.3
-
26
-
-
0026599635
-
Influence of cannabis abuse on schizophrenic psychopathology
-
Peralta V, Cuesta MJ. Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatr Scand. 1992;85:127-130.
-
(1992)
Acta Psychiatr Scand
, vol.85
, pp. 127-130
-
-
Peralta, V.1
Cuesta, M.J.2
-
27
-
-
0026011476
-
Substance abuse and schizophrenia: Effect on symptoms but not on neurocognitive function
-
Cleghorn JM, Kaplan RD, Szechtman H, et al. Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function. J Clin Psychiatry. 1991;52:26-30.
-
(1991)
J Clin Psychiatry
, vol.52
, pp. 26-30
-
-
Cleghorn, J.M.1
Kaplan, R.D.2
Szechtman, H.3
-
28
-
-
0023036287
-
Cannabis affects the severity of schizophrenic symptoms: Results of a clinical survey
-
Negrete JC, Knapp WP, Douglas DE, et al. Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychol Med. 1986;16:512-520.
-
(1986)
Psychol Med
, vol.16
, pp. 512-520
-
-
Negrete, J.C.1
Knapp, W.P.2
Douglas, D.E.3
-
29
-
-
0024566820
-
Recall and dating of psychiatric symptoms. Test-retest reliability of time-related symptom questions in a standardized psychiatric interview
-
Wittchen HU, Burke JD, Semler G, et al. Recall and dating of psychiatric symptoms. Test-retest reliability of time-related symptom questions in a standardized psychiatric interview. Arch Gen Psychiatry. 1989;46:437-443.
-
(1989)
Arch Gen Psychiatry
, vol.46
, pp. 437-443
-
-
Wittchen, H.U.1
Burke, J.D.2
Semler, G.3
-
30
-
-
0034899652
-
The reliability of self reported age of onset of tobacco, alcohol and illicit drug use
-
Johnson TP, Mott JA. The reliability of self reported age of onset of tobacco, alcohol and illicit drug use. Addiction. 2001;96:1187-1198.
-
(2001)
Addiction
, vol.96
, pp. 1187-1198
-
-
Johnson, T.P.1
Mott, J.A.2
-
31
-
-
36048931078
-
Accuracy of self-reported premorbid functioning in schizophrenia
-
Brill N, Reichenberg A, Rabinowitz J, et al. Accuracy of self-reported premorbid functioning in schizophrenia. Schizophr Res. 2007;97:103-108.
-
(2007)
Schizophr Res
, vol.97
, pp. 103-108
-
-
Brill, N.1
Reichenberg, A.2
Rabinowitz, J.3
|